Page 4 - Johan Dighed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johan dighed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johan Dighed Today - Breaking & Trending Today

Karolinska Development's portfolio company PharmNovo reports positive results from a clinical phase 1 study of drug candidate PN6047

STOCKHOLM, SWEDEN, October 2, 2023. Karolinska Development AB announces that its portfolio company PharmNovo has successfully completed its clinical phase 1 study with PN6047, a drug candidate. ....

Karolinska Institutet , Johan Dighed , Viktor Drvota , Karolinska Development , Karolinska Development Ab Nasdaq Stockholm , Nasdaq Stockholm , General Counsel ,

Karolinska Development's portfolio company PharmNovo reports promising preclinical results on abuse potential and withdrawal symptom relief for its candidate drug PN6047

STOCKHOLM, SWEDEN, September 28, 2023. Karolinska Development AB announces that its portfolio company PharmNovo has reported promising results in a preclinical study of the company’s drug candidate. ....

United States , Karolinska Institutet , Viktor Drvota , Johan Dighed , Us National Institute Of Drug Abuse , Washington University , University Of Michigan , Karolinska Development , Karolinska Development Ab Nasdaq Stockholm , Nasdaq Stockholm , Drug Abuse , General Counsel ,

Karolinska Development's portfolio company OssDsign raises SEK 150 million and makes strategic move to become a pure play orthobiologics company

STOCKHOLM, SWEDEN, September 27, 2023. Karolinska Development AB announces that its portfolio company OssDsign successfully has completed a directed share issue to a value of approximately SEK 150. ....

Johan Dighed , Viktor Drvota , Karolinska Institutet , Karolinska Development , Karolinska Development Ab Nasdaq Stockholm , Investment Fund , Nasdaq Stockholm , Ossdsign Catalyst , General Counsel ,

Karolinska Development's portfolio company OssDsign has received FDA clearance for a new major indication

STOCKHOLM, SWEDEN, September 19, 2023. Karolinska Development AB announces that its portfolio company OssDsign has received clearance from FDA for the use of OssDsign Catalyst in interbody cages in. ....

Karolinska Institutet , Johan Dighed , Viktor Drvota , Drug Administration , Karolinska Development Ab Nasdaq Stockholm , Karolinska Development , Investment Fund , Nasdaq Stockholm , Ossdsign Catalyst , Dsign Catalyst , Nasdaq First North Growth Market , General Counsel ,

Karolinska Development's portfolio company OssDsign has received FDA clearance for a new major indication

Karolinska Development's portfolio company OssDsign has received FDA clearance for a new major indication
orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.

Viktor Drvota , Karolinska Institutet , Johan Dighed , Investment Fund , Karolinska Development , Karolinska Development Ab Nasdaq Stockholm , Drug Administration , Nasdaq Stockholm , Ossdsign Catalyst , Dsign Catalyst , Nasdaq First North Growth Market , General Counsel ,